Abcam's CEO wins Mediscience award

CambridgeUK,June20,2014:Abcamplc.,aleADIngproviderofinnovativeproteinresearchtoolsandservices,ispleasedtoannouncethatitsCEO,DrJonathanMilner,haswontheEuropeanMediscienceawardforthe"MostsignificantcontributiontotheMedisciencesector".

Pictureshows,lefttoright:ErikManting,ExecutiveDirector,LifeSciencesandHealth,Kempen&Co;Dr.BrianWhite,ShoreCapital;JonathanMilner(winner);andLouiseMinchin,awardspresenter.

TheEuropeanMediscienceAwardsisthelargestannualgatheringofprivateandpubliclyquotedhealthcare,biotechandlifesciencescompaniesinEurope.Theawardscelebratethebestbreakthroughs,technologyandsignificantcontributionsfromindividualsandcompaniesintheMedisciencesector.

Jonathan"scommittmenttotheMedisciencesectorisdrivenbyapassionforabetterunderstandingofhumanhealthanddisease.StartingoutasabreastcancerresearcherattheUniversityofCambridge,andfrustratedbyalackofhigh-qualityantibodiesinthemarket,JonathanfoundedAbcamin1998.Dubbedthe"AmazonofAntibodies"foritsuniquedata-richproducts,theCompanyhasevolvedfromhumblebeginningsandisnowamarketleaderprovidinginnovativeproductssuchasRaBMAb®primariesandarangeofotherlifescienceproductstohelpadvanceproteinresearchglobally.

Inrecentyears,JonathanhasbeeninvolvedwithseveralexcitingresearchinitiativesandistheprincipleinvestorinHorizonDiscoveryandco-founderofAxolBioscience.

"I"mdelightedtohavewontheawardforthemostsignificantcontributiontotheMedisciencesector.AtAbcam,we"repassionateaboutacceleratingthepaceofscientificdiscoveriestobetterunderstandhumanhealthanddisease.Iwouldliketothankouremployeeswhoarededicatedtoourmissionofenablingscientiststodiscovermore”

-DrJonathanMilner,CEO,Abcam